HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Louis M Staudt Selected Research
Louis M Staudt Research Topics
Disease
81
Neoplasms (Cancer)
05/2024 - 01/2002
53
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 04/2002
39
Lymphoma (Lymphomas)
04/2024 - 07/2002
18
B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 12/2002
13
Burkitt Lymphoma (Burkitt's Lymphoma)
04/2024 - 06/2006
9
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 11/2005
7
Disease Progression
10/2021 - 07/2002
6
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 07/2002
6
Multiple Myeloma
01/2021 - 08/2007
5
Leukemia
05/2017 - 07/2002
4
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022 - 05/2014
3
Genetic Translocation (Chromosomal Translocation)
12/2021 - 12/2002
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021 - 01/2007
3
Carcinogenesis
11/2009 - 04/2006
2
Aspergillosis
05/2024 - 12/2017
2
Anemia
01/2021 - 08/2017
2
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019 - 05/2014
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016 - 06/2003
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2013 - 08/2012
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2013 - 08/2012
2
Hematologic Neoplasms (Hematological Malignancy)
04/2012 - 05/2006
2
Hodgkin Disease (Hodgkin's Disease)
03/2011 - 03/2010
2
Plasmacytoma
11/2005 - 09/2005
2
Infections
08/2004 - 04/2004
1
Systemic Scleroderma (Systemic Sclerosis)
12/2023
Drug/Important Bio-Agent (IBA)
19
Proteins (Proteins, Gene)
FDA Link
01/2021 - 12/2002
16
NF-kappa B (NF-kB)
IBA
09/2010 - 07/2002
14
Rituximab (Mabthera)
FDA Link
04/2024 - 01/2007
12
ibrutinib
IBA
12/2021 - 02/2014
10
DNA (Deoxyribonucleic Acid)
IBA
10/2018 - 01/2002
9
Prednisone (Sone)
FDA Link
Generic
01/2021 - 12/2011
9
Vincristine (Oncovin)
FDA Link
Generic
01/2021 - 12/2011
9
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021 - 12/2011
9
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2021 - 12/2011
8
Antigens
IBA
10/2021 - 01/2002
8
Biomarkers (Surrogate Marker)
IBA
05/2017 - 05/2003
7
Agammaglobulinaemia Tyrosine Kinase
IBA
05/2024 - 04/2015
7
Transcription Factors (Transcription Factor)
IBA
10/2018 - 05/2006
7
Complementary DNA (cDNA)
IBA
08/2007 - 04/2002
6
Ligands
IBA
04/2024 - 11/2005
6
Paraffin
IBA
05/2017 - 06/2011
6
Phosphotransferases (Kinase)
IBA
04/2016 - 06/2010
5
Cyclin D1
IBA
01/2021 - 02/2003
5
Cyclins
IBA
01/2021 - 12/2005
5
Formaldehyde (Formol)
FDA Link
05/2017 - 06/2011
5
Messenger RNA (mRNA)
IBA
01/2013 - 02/2003
4
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
04/2024 - 02/2014
4
Chromatin
IBA
01/2021 - 01/2012
4
carboxyl radical (COO-)
IBA
01/2021 - 06/2011
4
Interleukin-6 (Interleukin 6)
IBA
01/2020 - 09/2005
4
Etoposide (VP 16)
FDA Link
Generic
01/2019 - 04/2013
4
Immunoglobulin M (IgM)
IBA
11/2015 - 04/2004
4
MicroRNAs (MicroRNA)
IBA
02/2015 - 09/2008
4
RNA (Ribonucleic Acid)
IBA
01/2013 - 08/2010
4
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
11/2005 - 06/2003
3
Polysaccharides (Glycans)
IBA
04/2024 - 10/2021
3
Ubiquitin
IBA
12/2021 - 04/2014
3
Lenalidomide (CC 5013)
FDA Link
01/2021 - 06/2012
3
Histones (Histone)
IBA
01/2021 - 12/2010
3
Antibodies
IBA
01/2019 - 10/2014
3
Immunoglobulins (Immunoglobulin)
IBA
02/2014 - 12/2002
3
Bortezomib (Velcade)
FDA Link
08/2012 - 06/2009
3
I-kappa B Kinase
IBA
06/2010 - 01/2005
3
Cyclin D2
IBA
11/2009 - 02/2004
2
Epitopes
IBA
04/2024 - 10/2014
2
Autoantigens
IBA
01/2023 - 11/2015
2
Circulating Tumor DNA
IBA
11/2022 - 01/2016
2
Mechanistic Target of Rapamycin Complex 1
IBA
10/2022 - 10/2021
2
Ligases (Synthetase)
IBA
12/2021 - 01/2015
2
Histocompatibility Antigens Class I
IBA
12/2021 - 01/2019
2
Immunoglobulin Variable Region
IBA
10/2021 - 01/2019
2
Protein Isoforms (Isoforms)
IBA
01/2021 - 01/2021
2
Cyclin D3
IBA
10/2020 - 12/2005
2
Anaplastic Lymphoma Kinase
IBA
11/2019 - 05/2014
2
Cytidine Deaminase
IBA
01/2019 - 03/2007
2
Interleukin-10 (Interleukin 10)
IBA
11/2016 - 04/2008
2
Small Interfering RNA (siRNA)
IBA
04/2016 - 11/2012
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
05/2013 - 11/2009
2
Interleukins
IBA
05/2013 - 02/2003
2
Elements
IBA
11/2012 - 11/2009
2
Tetracycline (Achromycin)
FDA Link
Generic
11/2012 - 05/2009
2
Interferons
IBA
06/2012 - 04/2007
2
MHC class II transactivator protein
IBA
03/2011 - 11/2009
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2009 - 01/2008
2
Antigen Receptors (Antigen Receptor)
IBA
03/2009 - 03/2008
1
src-Family Kinases
IBA
04/2024
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
04/2024
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
04/2024
1
polatuzumab vedotin
IBA
04/2024
1
Glucocorticoids
IBA
04/2024
1
Glycosyltransferases
IBA
04/2024
1
Chemokines
IBA
12/2023
1
Janus Kinase Inhibitors
IBA
10/2023
1
Complement System Proteins (Complement)
IBA
11/2022
1
eprenetapopt
IBA
10/2022
1
palbociclib
IBA
10/2022
Therapy/Procedure
30
Therapeutics
01/2023 - 02/2003
9
Drug Therapy (Chemotherapy)
01/2019 - 06/2002
7
Precision Medicine
04/2024 - 01/2017
1
Complementary Therapies (Alternative Medicine)
11/2022